2m 2m 2m 2m 2m 2m 2m
Kraig Biocraft (KBLB)
OTC
$0.12-$0.006 (-5.00%)
Price as of Jun 03, 2026- $135.7MMarket Cap
- 43.07%1-Year Change
- Specialty ChemicalsIndustry
Kraig Biocraft (KBLB)
$0.12-$0.006 (-5.00%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 233,028 N/A | N/A N/A | 109,559 N/A | N/A N/A | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 233,028 N/A | 0 -100.00% | 109,559 N/A | 0 -100.00% | |
Sales and Marketing Expense | 0 N/A | 0 N/A | 0 N/A | N/A N/A | |
Research and Development Expense | -165,758 +0.84% | -164,374 -30.90% | -237,871 +34.82% | -176,431 -10.78% | |
Depreciation and Amortization Expense | 25,113 -4.00% | 26,159 -5.29% | 27,620 -1.72% | 28,103 +7.52% | |
Total Operating Expenses | 3.4M +9.77% | 3.1M +17.58% | 2.6M +23.26% | 2.1M -23.13% | |
Operating Profit | -3.4M +9.77% | -3.1M +17.58% | -2.6M +23.26% | -2.1M -23.13% | |
Interest Income | 11,518 -83.87% | 71,396 -34.83% | 109,559 N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -153,955 0.00% | -153,955 -35.34% | |
Interest Income and Expense and Net | 11,518 -83.87% | 71,396 +260.82% | -44,396 -71.16% | -153,955 -35.34% | |
Total Nonoperating Income and Expense | -248,560 -23.37% | -324,378 -21.83% | -414,986 -75.88% | -1.7M -67.45% | |
Income before Taxes | -3.6M +6.60% | -3.4M +12.18% | -3.0M -21.14% | -3.8M -52.25% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | 95,872 N/A | N/A N/A | |
Net Income | 3.6M +6.60% | 3.4M +212.18% | -3.0M -21.14% | -3.8M -52.25% | |
Net Income from Continuing Operations Applicable to Common | -3.6M +6.60% | -3.4M +12.18% | -3.0M -21.14% | -3.8M -52.25% | |
Basic EPS and Net Income | 0.00 N/A | 0.00 N/A | 0.00 N/A | 0.00 +100.00% | |
Diluted EPS and Net Income | 0.00 N/A | 0.00 N/A | 0.00 N/A | 0.00 +100.00% | |
Basic Weighted Average Shares | 1.1B +2.03% | 1.0B +0.51% | 1.0B +6.04% | 974.3M +11.02% | |
Diluted Weighted Average Shares | 1.1B +2.03% | 1.0B +0.51% | 1.0B +6.04% | 974.3M +11.02% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.8M +165.90% | 673,264 -73.62% | 2.6M -33.94% | 3.9M +64.02% | |
Short-Term Investments | 0 N/A | 0 N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 1.8M +165.90% | 673,264 -73.62% | 2.6M -33.94% | 3.9M +64.02% | |
Total Current Assets | 1.9M +152.42% | 740,285 -71.24% | 2.6M -35.39% | 4.0M +68.35% | |
Accumulated Depreciation | 245,133 +10.60% | 221,633 +13.38% | 195,474 +16.45% | 167,854 +20.11% | |
Property and Plant and Equipment and Net | 25,003 -44.09% | 44,721 -32.89% | 66,640 -24.15% | 87,861 -20.81% | |
Total Long-Term Assets | 25,003 -44.09% | 44,721 -32.89% | 66,640 -24.15% | 87,861 -20.81% | |
Total Assets | 2.6M +70.43% | 1.5M -53.44% | 3.2M -29.27% | 4.6M +51.26% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 1.5M -7.73% | 1.6M -2.13% | 1.7M -3.50% | 1.7M -22.89% | |
Total Current Liabilities | 10.4M +8.64% | 9.6M +8.20% | 8.9M +10.08% | 8.1M -1.11% | |
Total Long-Term Debt | 1.9M 0.00% | 1.9M +966.47% | 180,244 +56.40% | 115,244 +21.00% | |
Total Long-Term Liabilities | 119,253 +194.26% | 40,526 -25.46% | 54,368 +162.69% | 20,697 -65.45% | |
Total Liabilities | 10.6M +9.42% | 9.7M +8.00% | 8.9M +10.47% | 8.1M -2.71% | |
Retained Earnings | -56.7M +6.83% | -53.1M +6.84% | -49.7M +6.49% | -46.7M +8.97% | |
Total Stockholders Equity | N/A N/A | N/A N/A | -5.7M +62.05% | -3.5M -33.50% | |
Total Shares Outstanding | 1.1B +4.39% | 1.0B 0.00% | 1.0B +0.72% | 1.0B +11.17% | |
Cash Flow | |||||
Cash from Operating Activities | -1.8M -2.73% | -1.8M +47.78% | -1.2M -34.06% | -1.9M +4.80% | |
Capital Expenditures | 5,395 +27.24% | 4,240 -33.74% | 6,399 +27.44% | 5,021 -94.83% | |
Cash from Investing Activities | 438,042 +10,431.18% | -4,240 -33.74% | -6,399 +27.44% | -5,021 -99.08% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 2.5M +7,102.33% | -35,244 -41.26% | -60,000 -101.76% | 3.4M -12.52% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -1,448.23% N/A | N/A N/A | -2,386.65% N/A | N/A N/A | |
Return on Assets | 178.01% +24.08% | 143.47% +284.77% | -77.65% -23.27% | -101.20% -72.96% | |
Return on Equity | N/A N/A | N/A N/A | 65.66% -24.66% | 87.14% -35.72% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Current Ratio | 0.18 +132.34% | 0.08 -73.41% | 0.29 -41.32% | 0.49 +70.23% | |
Cash Ratio | 0.17 +144.86% | 0.07 -75.63% | 0.29 -39.98% | 0.48 +65.86% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | -0.32 -38.12% | -0.52 +18.66% | |
Debt-to-Assets Ratio | 1.33 -43.40% | 2.35 +314.80% | 0.57 +41.77% | 0.40 -47.83% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow